Integer Holdings Co. (NYSE:ITGR) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Integer Holdings Co. (NYSE:ITGR) have been given an average recommendation of “Moderate Buy” by the seven research firms that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $133.86.

A number of brokerages recently commented on ITGR. Benchmark restated a “buy” rating and set a $130.00 target price on shares of Integer in a report on Friday, August 2nd. Oppenheimer began coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 target price on the stock.

Insider Activity at Integer

In other Integer news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares in the company, valued at $272,824.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Public Employees Retirement Association of Colorado raised its stake in shares of Integer by 3,260.1% in the fourth quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after purchasing an additional 276,944 shares during the last quarter. Norges Bank purchased a new position in Integer in the 4th quarter worth about $18,697,000. Driehaus Capital Management LLC lifted its stake in Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after acquiring an additional 135,750 shares during the period. F M Investments LLC purchased a new stake in shares of Integer during the 2nd quarter valued at about $11,143,000. Finally, Point72 Europe London LLP bought a new stake in shares of Integer in the second quarter worth approximately $6,241,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Down 1.6 %

Shares of Integer stock opened at $129.33 on Wednesday. The company’s 50 day moving average price is $122.98 and its 200-day moving average price is $118.66. Integer has a 52-week low of $69.40 and a 52-week high of $131.87. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The stock has a market capitalization of $4.33 billion, a price-to-earnings ratio of 44.75, a P/E/G ratio of 1.81 and a beta of 1.09.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. The firm had revenue of $436.20 million for the quarter, compared to analysts’ expectations of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.14 earnings per share. Equities research analysts forecast that Integer will post 5.31 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.